Literature DB >> 12912884

A yeast under cover: the capsule of Cryptococcus neoformans.

Indrani Bose1, Amy J Reese, Jeramia J Ory, Guilhem Janbon, Tamara L Doering.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12912884      PMCID： PMC178345          DOI： 10.1128/EC.2.4.655-663.2003

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN： 1535-9786


× No keyword cloud information.
  109 in total

1.  Spatial and temporal sequence of capsule construction in Cryptococcus neoformans.

Authors:  L M Pierini; T L Doering
Journal:  Mol Microbiol       Date:  2001-07       Impact factor: 3.501

2.  Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity.

Authors:  E A Wills; I S Roberts; M Del Poeta; J Rivera; A Casadevall; G M Cox; J R Perfect
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

3.  The second STE12 homologue of Cryptococcus neoformans is MATa-specific and plays an important role in virulence.

Authors:  Y C Chang; L A Penoyer; K J Kwon-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans.

Authors:  P Wang; M E Cardenas; G M Cox; J R Perfect; J Heitman
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

5.  Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans.

Authors:  D Pietrella; R Cherniak; C Strappini; S Perito; P Mosci; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 6.  How does Cryptococcus get its coat?

Authors:  T L Doering
Journal:  Trends Microbiol       Date:  2000-12       Impact factor: 17.079

Review 7.  The Cryptococcus neoformans genome sequencing project.

Authors:  J Heitman; A Casadevall; J K Lodge; J R Perfect
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

8.  Serologic evidence for Cryptococcus neoformans infection in early childhood.

Authors:  D L Goldman; H Khine; J Abadi; D J Lindenberg; R Niang; A Casadevall
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

Review 9.  Conserved cAMP signaling cascades regulate fungal development and virulence.

Authors:  C A D'Souza; J Heitman
Journal:  FEMS Microbiol Rev       Date:  2001-05       Impact factor: 16.408

10.  Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans.

Authors:  C A D'Souza; J A Alspaugh; C Yue; T Harashima; G M Cox; J R Perfect; J Heitman
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272
View more
  103 in total

Review 1.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

2.  Sulphiredoxin plays peroxiredoxin-dependent and -independent roles via the HOG signalling pathway in Cryptococcus neoformans and contributes to fungal virulence.

Authors:  Rajendra Upadhya; Hyelim Kim; Kwang-Woo Jung; Goun Park; Woei Lam; Jennifer K Lodge; Yong-Sun Bahn
Journal:  Mol Microbiol       Date:  2013-10-03       Impact factor: 3.501

3.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

4.  Yeasts in an industrial malting ecosystem.

Authors:  A Laitila; A Wilhelmson; E Kotaviita; J Olkku; S Home; R Juvonen
Journal:  J Ind Microbiol Biotechnol       Date:  2006-06-07       Impact factor: 3.346

5.  CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans.

Authors:  Y C Chang; A Jong; S Huang; P Zerfas; K J Kwon-Chung
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.

Authors:  Leonardo Nimrichter; Susana Frases; Leonardo P Cinelli; Nathan B Viana; Antonio Nakouzi; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2007-06-15

Review 7.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.

Authors:  Magdia De Jesus; André Moraes Nicola; Marcio L Rodrigues; Guilhem Janbon; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2008-10-24

9.  Three galactose inducible promoters for use in C. neoformans var. grubii.

Authors:  Jack A Ruff; Jennifer K Lodge; Lorina G Baker
Journal:  Fungal Genet Biol       Date:  2008-10-14       Impact factor: 3.495

10.  The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.

Authors:  Richard W Stokes; Raymond Norris-Jones; Donald E Brooks; Terry J Beveridge; Dan Doxsee; Lisa M Thorson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.